Industry

Adds natural language processing to Viz.ai’s AI-powered platform to detect suspected disease earlier and monitor patients SAN FRANCISCO–(BUSINESS WIRE)–#AI—Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced a partnership with Illuminate, Inc., an industry leader in the development of proprietary natural language processing (NLP) and AI software that discovers at-risk patients … [Read more…]

SANTA CLARA, Calif.–(BUSINESS WIRE)–Agilent Technologies Inc. (NYSE: A) today announced that Mike McMullen, president and chief executive officer, and Bob McMahon, chief financial officer, will present at the 5th Annual Evercore ISI HealthCONx conference on Wednesday, November 30, at 10:50 a.m. PST. A live webcast and audio archive of the virtual session will be available … [Read more…]

VANCOUVER, British Columbia–(BUSINESS WIRE)–At Elumind Centres for Brain Excellence, we recognize and prioritize the brain as the most important aspect of vitality and health in everything that a person is and does. We believe that by addressing the human body and mind, we can empower people toward a healthier brain and, as a result, a … [Read more…]

Twist to report fiscal Q4 and full year 2022 financial results before market Friday, November 18, and host a conference call at 8:00 a.m. Eastern Time SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today addressed a … [Read more…]

Now available to Arizona patients! Non-invasive Smart Stickers™ that lift skin cells to be tested for select genomic markers associated with melanoma. LA JOLLA, Calif. & PHOENIX–(BUSINESS WIRE)–DermTech, Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today an agreement with Sonora Quest Laboratories … [Read more…]

Third quarter 2022 sales of $2.1 billion, up 2%, or 9% constant currency (cc) Third quarter 2022 earnings were $0.23 per diluted share; core earnings of $0.50 per diluted share, down 7%, or up 14% cc Updated 2022 outlook reflects strong sales growth and operational leverage, negatively impacted by strong US dollar Ad Hoc Announcement … [Read more…]

EsoGuard test volume shows steady sequential growth Veris Cancer Care Platform poised for commercial launch Conference call and webcast to be held today at 4:30 PM EDT NEW YORK–(BUSINESS WIRE)–$PAVM #1x1meetings—PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, … [Read more…]

SALT LAKE CITY–(BUSINESS WIRE)–Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the fourth quarter of fiscal year 2022. Q4 FY22 Summary Record revenues of $231 million GAAP gross margin 32% | Non-GAAP gross margin* 33% GAAP operating expense $50 million | Non-GAAP operating expense* $47 million GAAP operating margin 11% | … [Read more…]

SAN FRANCISCO–(BUSINESS WIRE)–Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that Anna Bryson, CFO, will participate in a fireside chat at Raymond James Technology Investor Conference on Monday, December 5, 2022, at 10:20 a.m. Eastern Time/7:20 a.m Pacific Time. About Doximity Founded in 2010, Doximity is the leading digital … [Read more…]

Conference Call/Webcast Today at 5 pm ET TORONTO & DALLAS–(BUSINESS WIRE)–$PINK.V #AI–Perimeter Medical Imaging AI, Inc. (TSX-V: PINK) (OTC: PYNKF) (FSE: 4PC) (“Perimeter” or the “Company”) – a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address high unmet medical needs – today reported financial results for its … [Read more…]